| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.086 | 0.6 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.091 | 0.6 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.6 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |